HOXD11 and metastatic malignant neoplasm in the lymph nodes: In addition, IHC was performed with an mPSCC patient with retroperitoneal lymph node metastases, and we found that HOXD11 was strongly expressed in tumors, especially in metastatic lesions (Fig. 1E).